Skip to main content
. 2015 Nov 16;15:903. doi: 10.1186/s12885-015-1924-3

Table 1.

Correlation of CD44s expression with demographics and histopathological findings in patients with ampullary adenocarcinoma who underwent resection

Extent of CD44s expressiona
Negative or weak (< 25 %) Moderate or dense (≥ 25 %) P-value
Patients, number (%) 55 (56 %) 43 (44 %)
Age, y, mean (range) 65 (32–90) 65 (35–84) 0.971
Sex 0.839
 Female 26 (58 %) 19 (42 %)
 Male 29 (55 %) 24 (45 %)
Histology typeb 0.139
 Intestinal 26 (54 %) 22 (46 %)
 Pancreaticobiliary 19 (73 %) 7 (27 %)
Gross tumor type 0.059
 Polypoid 24 (45 %) 29 (55 %)
 Ulcerative 17 (71 %) 7 (29 %)
 Mixed 14 (67 %) 7 (33 %)
Tumor size, cm 2.1 (0.7–8.0) 2.2 (0.8–5.5) 0.625
Differentiationb 0.904
 Well 26 (58 %) 19 (42 %)
 Moderate 24 (59 %) 17 (41 %)
 Poor 4 (50 %) 4 (50 %)
Lymphovascular invasionb 0.006
 Negative 13 (39 %) 20 (61 %)
 Positive 24 (75 %) 8 (25 %)
Perineural invasionb 0.558
 Negative 19 (56 %) 15 (44 %)
 Positive 12 (67 %) 6 (33 %)
Resection margin 0.167
 Free 48 (55 %) 40 (45 %)
 Microscopically positive 7 (78 %) 2 (22 %)
 Macroscopically positive 0 1 (100 %)
Pancreatic invasionb 0.004
 Negative 19 (40 %) 29 (60 %)
 Positive 34 (71 %) 14 (29 %)
Tumor stage 0.034
 pT1 3 (33 %) 6 (67 %)
 pT2 17 (44 %) 22 (56 %)
 pT3 23 (68 %) 11 (32 %)
 pT4 12 (75 %) 4 (25 %)
Lymph node metastasisb 0.289
 pN0 30 (52 %) 28 (48 %)
 pN1 23 (64 %) 13 (36 %)
AJCC TNM stage 0.019
 Stage I 16 (42 %) 22 (58 %)
 Stage II 27 (64 %) 15 (36 %)
 Stage III 12 (75 %) 4 (25 %)
 Stage IV 0 2 (100 %)

Abbreviations: AJCC TNM stage, American Joint Committee on Cancer tumor, node, metastases staging system

aAs determined by univariate analysis

bExcluding patients without detailed recorded